CytRx Corp.
(Other OTC/NBB : CYTR)

( )
CYTR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 5.32%76.066.2%$205.22m
VRXValeant Pharmaceuticals International, Inc. -10.38%18.0414.1%$106.15m
CTLTCatalent, Inc. -0.03%88.162.2%$89.17m
JAZZJazz Pharmaceuticals Plc -0.78%126.082.4%$76.67m
BHCBausch Health Cos., Inc. -10.38%18.040.0%$75.32m
TNXPTonix Pharmaceuticals Holding Corp. -3.33%1.160.5%$57.52m
PRGOPerrigo Co. Plc -0.02%50.456.8%$45.46m
ARGXargenx SE -0.15%230.760.0%$42.63m
GWPHGW Pharmaceuticals Plc -17.21%109.376.2%$42.38m
ICLRICON plc 0.30%189.914.3%$41.81m
PCRXPacira Biosciences, Inc. 0.38%58.3510.3%$39.85m
AMRNAmarin Corp. Plc -0.71%7.001.5%$39.83m
MYOKMyoKardia, Inc. 3.12%103.401.8%$38.76m
ICPTIntercept Pharmaceuticals, Inc. 3.33%48.7516.8%$38.58m
UTHRUnited Therapeutics Corp. 0.53%112.7914.1%$37.15m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.